Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangement - Wikidata - awgldk - TriplyDB

Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangement

Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangement

http://www.wikidata.org/entity/Q30160287

about

The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex Abi1/Hssh3bp1 pY213 links Abl kinase signaling to p85 regulatory subunit of PI-3 kinase in regulation of macropinocytosis in LNCaP cells Phosphoinositides: tiny lipids with giant impact on cell regulation Multiple phosphatidylinositol 3-kinases regulate vaccinia virus morphogenesis Genetic insights into the mechanisms of Fgf signaling PI3K/PTEN signaling in angiogenesis and tumorigenesis LRP1 regulates architecture of the vascular wall by controlling PDGFRbeta-dependent phosphatidylinositol 3-kinase activation PI3K-mediated PDGFRα signaling regulates survival and proliferation in skeletal development through p53-dependent intracellular pathways Phosphoinositide 3-kinase p85beta regulates invadopodium formation.PI3K activation is required for PMA-directed activation of cSrc by AFAP-110.Phosphoinositide 3-Kinase C2beta regulates cytoskeletal organization and cell migration via Rac-dependent mechanisms.Acute effects of leptin require PI3K signaling in hypothalamic proopiomelanocortin neurons in mice.RNAi screen of endoplasmic reticulum-associated host factors reveals a role for IRE1alpha in supporting Brucella replication.Modulation of epithelial neoplasia and lymphoid hyperplasia in PTEN+/- mice by the p85 regulatory subunits of phosphoinositide 3-kinase Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy.p85beta phosphoinositide 3-kinase regulates CD28 coreceptor function Microglial MAC1 receptor and PI3K are essential in mediating β-amyloid peptide-induced microglial activation and subsequent neurotoxicity Oncogenic activity of the regulatory subunit p85β of phosphatidylinositol 3-kinase (PI3K)Downregulation of PI3Kcb utilizing adenovirus-mediated transfer of siRNA attenuates bone cancer pain.Identification of mutations in distinct regions of p85 alpha in urothelial cancer.Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase.AKT phosphorylation is essential for insulin-induced relaxation of rat vascular smooth muscle cells T-cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling.Simvastatin inhibits Staphylococcus aureus host cell invasion through modulation of isoprenoid intermediates.The p85alpha regulatory subunit of phosphoinositide 3-kinase potentiates c-Jun N-terminal kinase-mediated insulin resistance.PERK utilizes intrinsic lipid kinase activity to generate phosphatidic acid, mediate Akt activation, and promote adipocyte differentiation p85β phosphoinositide 3-kinase subunit regulates tumor progression Reelin signals through phosphatidylinositol 3-kinase and Akt to control cortical development and through mTor to regulate dendritic growth.Class 1A PI3K regulates vessel integrity during development and tumorigenesis.Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells Activation of T cells by cross-linking Qa-2, the ped gene product, requires Fyn.Many roads lead to oncogene-induced senescence.Myristoylated p110α Causes Embryonic Death Due to Developmental and Vascular Defects.cAMP-GEF cytoprotection by Src tyrosine kinase activation of phosphoinositide-3-kinase p110 beta/alpha in rat hepatocytes Oncogene-induced senescence: an essential role for Runx.PDGFRβ regulates craniofacial development through homodimers and functional heterodimers with PDGFRα Beta interferon regulation of glucose metabolism is PI3K/Akt dependent and important for antiviral activity against coxsackievirus B3.The regulation of tumor-suppressive microRNA, miR-126, in chronic lymphocytic leukemia.Is prenatal myo-inositol deficiency a mechanism of CNS injury in galactosemia?Overexpression of 14-3-3ζ in cancer cells activates PI3K via binding the p85 regulatory subunit.

P2860

Q24310123-FAC6F01D-2795-4680-8869-BB9AFE6CDB2F Q24337290-536EAF94-63C7-40E5-8E66-2A3507AA0682 Q27012953-0D4E5E49-4516-46F5-B4BC-5F2A732A3133 Q27325801-570BFE1D-C22A-46DF-8887-B7537E45D385 Q28066570-8A1EA9D0-FEAA-4333-8422-81ED89270CB2 Q28383083-5A77AB12-826D-41BD-B1B7-BDB8A93575EF Q28508492-CE76811C-5E45-4CBE-AAD6-98CE8F3A8F03 Q28512064-212B1989-9DDD-413D-898D-05655301C510 Q29347240-2A6B0B0B-52C6-4B96-B3A3-F64D74C6D8EB Q30158027-EB421A73-08E0-408C-ABAD-05D5B7AD7BCB Q30478070-29188BBE-1102-4EF1-BB96-954325AF8AA0 Q30481572-BEA51627-7113-4160-8933-20840F970525 Q33354944-2EF119E2-700C-471C-B9D1-14138E6C50D4 Q33895741-4230FCA0-57C8-4F4F-A5BF-64658C55D899 Q34097448-B6D640C5-0D19-4ED7-B75F-2FE9AFBBEA80 Q34156303-9BA59B07-1E0B-402F-BE54-D75AE5E683B3 Q34521923-40C28719-ACE6-456D-BDC4-FE25CF522192 Q34601157-E87C45A6-978D-4E84-B889-660555A17537 Q34732967-88FEBC92-F065-4A94-9C34-4329A9F28414 Q35075756-55B34F24-991E-4E3C-89F6-89AA63075ADF Q35130783-E531F2B7-4234-4729-83A0-D640231C8811 Q35131182-E3272FCB-1702-4771-BD86-E01D7598A046 Q35750980-1FC657E1-DBB4-4ADD-8932-F0DC378AB97D Q35786296-27347BAC-4741-4057-9B43-0B2C6CA2ABF0 Q35856767-C321390D-A3E9-4BF1-B6B3-E352DA386C92 Q36023300-C49F2805-C8D6-4B74-964E-9FA5179C3CFA Q36094306-80C95EB8-390C-49BD-9885-5CDD91494119 Q36315309-E3CCADA6-F358-42DB-826B-223FD99A2A46 Q36755338-92B869FC-5109-426D-B706-258FB6633887 Q36835733-7F57DD09-F0FB-45A2-B18F-707AE89EB3B0 Q36862970-4ACC27A6-E354-4CC3-BA29-EC8F760E51C3 Q37056216-CC15F06E-00F1-4809-B517-B3F43DF1071F Q37138629-52B6F05A-15DD-450C-BB81-D4179AE5F2BC Q37162455-8165258D-558C-4441-98D0-BF5EA56BE465 Q37234252-1ED5D621-3F8A-4880-BE04-153DAB2F703A Q37461467-7EF1EA1A-A249-4C6F-8A0F-6ABA90B027A4 Q37643727-0D9DA2B4-ABE8-4878-9311-C4F399A741D5 Q37747342-7D614A8A-6975-4A58-9EF9-FE9507EE66CC Q37829953-5665966B-9204-4E69-B6EF-75E0318862EC Q38712325-13B2C925-536C-4B72-82D8-2140722F2568

P2860

Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangement

http://www.wikidata.org/entity/Q30160287

description

2005 nî lūn-bûn

@nan

2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Role of phosphoinositide 3-kin ...... opment and actin rearrangement

@ast

Role of phosphoinositide 3-kin ...... opment and actin rearrangement

@en

type

label

Role of phosphoinositide 3-kin ...... opment and actin rearrangement

@ast

Role of phosphoinositide 3-kin ...... opment and actin rearrangement

@en

prefLabel

Role of phosphoinositide 3-kin ...... opment and actin rearrangement

@ast

Role of phosphoinositide 3-kin ...... opment and actin rearrangement

@en

P1433

Q30160287-9B4D6BDE-8D73-4D49-A8D5-10889ECEF0A4

P1476

Q30160287-C2F9B081-9181-4082-8162-D84AC3012AD4

P2093

Q30160287-0AF6EB5F-1A3A-47AA-813A-A6CE7C612B98

Q30160287-15945DA4-317A-4430-90FD-699FB2E829DF

Q30160287-3C547DBF-2A56-470E-9621-88E1AFB070DB

Q30160287-9C403C66-AC57-4641-9057-0A28EFDD884A

Q30160287-A37CA9CC-7393-4B1A-84B7-357294043ECE

Q30160287-CE63262B-3B90-4163-8662-A0F2E3052865

P2860

Q30160287-06C82BE0-8F91-443C-B505-B3EC4860B14D

Q30160287-0E59AE97-38E8-4E50-B229-94839CF809D2

Q30160287-19A451AD-C6BC-4B69-8475-B57B3EB54A13

Q30160287-221DC28F-2BBA-44E3-BD51-F81BFDB4ABBF

Q30160287-227DC727-49A6-4140-9C0D-9268DCE45B5B

Q30160287-26BE6D2B-4139-420B-97D2-9F5D9B15A610

Q30160287-28C94230-71BF-4281-AC39-2FE9605F2BBC

Q30160287-2B98E066-C79A-49B5-AC96-0BD573169F16

Q30160287-2EB9F4EC-5B7E-4701-811E-4ED5A960E5CC

Q30160287-3210F8F2-2D73-4B42-811D-B706B9BA290F

P304

Q30160287-B1F84B08-4D8F-4633-9AD2-685A1D4DA25C

P31

Q30160287-E57462C2-55B3-48AF-B161-48A7D6ED5714

P356

Q30160287-7E3A3564-2270-44A2-B5A2-5D833394351E

P407

Q30160287-02B92B21-51EF-4BC9-9764-6EBAD5F75FD0

P433

Q30160287-753D2370-A881-43FC-AD1C-706D5903D71D

P478

Q30160287-2D50E129-A949-4A1F-AD8B-E3244960A4B7

P50

Q30160287-349BF7C6-A774-49F7-B5AD-B5992640303F

P577

Q30160287-6425C5CF-5087-4983-9032-A5AEFA4DE30A

P5875

Q30160287-C2BAC284-FD6F-47CC-9C79-ACF5D04816A1

P698

Q30160287-6823DE42-BF88-463D-A58D-780A68DDCECA

P932

Q30160287-7C7291B3-27E8-49F2-8489-7A6B69EB95E3

P356

MCB.25.7.2593-2606.2005

P1433

Molecular and Cellular Biology

P1476

Role of phosphoinositide 3-kin ...... opment and actin rearrangement

@en

P2093

Claudine M Yballe

http://www.w3.org/2001/XMLSchema#string

David A Fruman

http://www.w3.org/2001/XMLSchema#string

Jonathan A Deane

http://www.w3.org/2001/XMLSchema#string

Lewis C Cantley

http://www.w3.org/2001/XMLSchema#string

Saskia M Brachmann

http://www.w3.org/2001/XMLSchema#string

Sheila M Thomas

http://www.w3.org/2001/XMLSchema#string

P2860

Human phosphoinositide 3-kinase C2beta, the role of calcium and the C2 domain in enzyme activity

Two signaling molecules share a phosphotyrosine-containing binding site in the platelet-derived growth factor receptor

Increased insulin sensitivity in mice lacking p85beta subunit of phosphoinositide 3-kinase

The N-terminal 24 amino acids of the p55 gamma regulatory subunit of phosphoinositide 3-kinase binds Rb and induces cell cycle arrest

The structure and function of p55PIK reveal a new regulatory subunit for phosphatidylinositol 3-kinase

Vav2 is required for cell spreading

Vav3 modulates B cell receptor responses by regulating phosphoinositide 3-kinase activation

The phosphoinositide 3-kinase pathway

High frequency of mutations of the PIK3CA gene in human cancers

Signalling through the lipid products of phosphoinositide-3-OH kinase

P304

2593-2606

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/MCB.25.7.2593-2606.2005

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Metello Innocenti

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7966484

http://www.w3.org/2001/XMLSchema#string

P698

15767666

http://www.w3.org/2001/XMLSchema#string

P932

1061637

http://www.w3.org/2001/XMLSchema#string